Cutting Edge: The PTPN22 Allelic Variant Associated with Autoimmunity Impairs B Cell Signaling

  • Adrian F Arechiga
    Translational Research Program, Benaroya Research Institute at Virginia Mason , Seattle, WA 98101
  • Tania Habib
    Translational Research Program, Benaroya Research Institute at Virginia Mason , Seattle, WA 98101
  • Yantao He
    Department of Biochemistry and Molecular Biology, Indiana University School of Medicine , Indianapolis IN 46202
  • Xian Zhang
    Department of Biochemistry and Molecular Biology, Indiana University School of Medicine , Indianapolis IN 46202
  • Zhong-Yin Zhang
    Department of Biochemistry and Molecular Biology, Indiana University School of Medicine , Indianapolis IN 46202
  • Andrew Funk
    Translational Research Program, Benaroya Research Institute at Virginia Mason , Seattle, WA 98101
  • Jane H Buckner
    Translational Research Program, Benaroya Research Institute at Virginia Mason , Seattle, WA 98101

書誌事項

公開日
2009-03
権利情報
  • https://academic.oup.com/pages/standard-publication-reuse-rights
DOI
  • 10.4049/jimmunol.0713370
公開者
Oxford University Press (OUP)

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:p>PTPN22 is a gene encoding the protein tyrosine phosphatase Lyp. A missense mutation changing residue 1858 from cytosine to thymidine (1858C/T) is associated with multiple autoimmune disorders. Studies have demonstrated that Lyp has an inhibitory effect on TCR signaling; however, the presence of autoantibodies in all of the diseases associated with the 1858T variant and recent evidence that Ca2+ flux is altered in B cells of 1858T carriers indicate a role for Lyp in B cell signaling. In this study we show that B cell signal transduction is impaired in individuals who express the variant. This defect in signaling is characterized by a deficit in proliferation, a decrease in phosphorylation of key signaling proteins, and is reversed by inhibition of Lyp. These findings suggest that the PTPN22 1858T variant alters BCR signaling and implicate B cells in the mechanism by which the PTPN22 1858T variant contributes to autoimmunity.</jats:p>

収録刊行物

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ